Method of treatment for sexual dysfunction

Details Method of treatment for sexual dysfunction Method of treatment for sexual dysfunction

2003-12-02

2008-10-07

Henley, III, Raymond J (Department: 1614)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Radical -xh acid, or anhydride, acid halide or salt thereof...

Reexamination Certificate

active

07432299

ABSTRACT:
Use of an alpha-2-delta ligand, or a pharmaceutically acceptable derivative thereof, for the manufacture of a medicament for the treatment of premature ejaculation.

REFERENCES:
patent: 2503059 (1950-04-01), Miescher et al.
patent: 2599000 (1952-06-01), Kerwin et al.
patent: 3381009 (1968-04-01), Palazzo et al.
patent: 3511836 (1970-05-01), Hess
patent: 3527761 (1970-09-01), Archibald et al.
patent: 3997666 (1976-12-01), Witte et al.
patent: 4024175 (1977-05-01), Satzinger et al.
patent: 4026894 (1977-05-01), Winn et al.
patent: 4188390 (1980-02-01), Campbell
patent: 4252721 (1981-02-01), Silvestrini et al.
patent: 4315007 (1982-02-01), Manoury
patent: 4703063 (1987-10-01), Imai et al.
patent: 5563175 (1996-10-01), Silverman et al.
patent: 5945117 (1999-08-01), El-Rashidy et al.
patent: 2003/0195251 (2003-10-01), Barta et al.
patent: 0641330 (2001-10-01), None
patent: 1178034 (2002-02-01), None
patent: 1201240 (2002-05-01), None
patent: 0934061 (2003-05-01), None
patent: WO 9111172 (1991-08-01), None
patent: WO 9402518 (1994-02-01), None
patent: WO 9729101 (1997-08-01), None
patent: WO 9733858 (1997-09-01), None
patent: WO 9733859 (1997-09-01), None
patent: WO 9817627 (1998-04-01), None
patent: WO 9855148 (1998-12-01), None
patent: WO 9921824 (1999-05-01), None
patent: WO 9930697 (1999-06-01), None
patent: WO 9931057 (1999-06-01), None
patent: WO 9931074 (1999-06-01), None
patent: WO 9931075 (1999-06-01), None
patent: WO 0061135 (2000-10-01), None
patent: WO 0076958 (2000-12-01), None
patent: WO 0128978 (2001-04-01), None
patent: WO 0222568 (2002-03-01), None
patent: WO 0228881 (2002-04-01), None
patent: WO 0230871 (2002-04-01), None
patent: WO 0230881 (2002-04-01), None
patent: WO 0242414 (2002-05-01), None
patent: WO 02/085839 (2002-09-01), None
patent: WO 02085839 (2002-10-01), None
patent: WO 02100347 (2002-12-01), None
patent: WO 02100392 (2002-12-01), None
patent: WO 03000642 (2003-01-01), None
patent: WO 03082807 (2003-10-01), None
Gee, et al., “The Novel Anticonvulsant Drug, Gabapentin (Neurontin), Binds to the α2ōSubunit of a Calcium Channel”,The Journal of Biological Chemistry271(10), pp. 5768-5776 (1996).
Williams, et al., “1-(((7,7-Dimethyl-2(S)-(2(S)-amino-4-(methysulfonyl)butyramido)bicyclo[2.2.1]-heptan-1(S)-yl)methyl)sulfonyl)-4-(2-mtheylphenyl)piperazine (L-368,899): An Orally Bioavailable, Non-Peptide Oxytocin Antagonist with Potential Utility for Managina Preterm Labor”,J. Med. Chem.37, pp. 565-571 (1994).
Yonezawa, et al., “Characterization of p-chloroamphetamine-induced penile erection and ejaculation in anesthetized rats”,Life Sciences67, pp. 3031-3039 (2000).
Tamkai, et al., “Synthesis of 4-cis-Phenyl-L-proline via Hydrogenolysis”,J. Org. Chem.66, pp. 3593-3596 (2001).
The Merck Manual, 6thEdition, “Orgasm Disorders”, pp. 1576-1577, by Merck Research Laboratories (1992).
Harden, et al., “Treatment of sexual disorders in people with epilepsy”,Epilepsy&Behavior, vol. 3, pp. S38-S41, (2002).

Affiliated with

Also associated with

Rating

Method of treatment for sexual dysfunction does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of treatment for sexual dysfunction, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treatment for sexual dysfunction will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4013109